SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-19-069103
Filing Date
2019-12-02
Accepted
2019-12-02 19:00:54
Documents
1
Period of Report
2019-11-27

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm1924318d1_4.html 4  
1 OWNERSHIP DOCUMENT tm1924318d1_4.xml 4 13262
  Complete submission text file 0001104659-19-069103.txt   14708
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 9360 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address
Weyer Christian (Reporting) CIK: 0001493811 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 191264261